Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

P Fenaux, D Haase, V Santini, GF Sanz… - Annals of …, 2021 - annalsofoncology.org
Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …
被引用次数：111 相关文章

[引用][C] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

P Fenaux, D Haase, V Santini… - Annals of oncology …, 2021 - pubmed.ncbi.nlm.nih.gov
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and
follow-up†☆ Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis …

[引用][C] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

P Fenaux, D Haase, V Santini, GF Sanz… - 2021 - publications.goettingen-research …
[PDF] meditool.cn

[PDF][PDF] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

P Fenaux, D Haase, V Santini, GF Sanz, U Platzbecker… - medi-guide.meditool.cn
Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

P Fenaux, D Haase, V Santini, GF Sanz… - ANNALS OF …, 2021 - flore.unifi.it
This ESMO Clinical Practice Guideline provides key recommendations for managing
myelodysplastic syndromes.• It covers diagnosis, classification, staging and risk assessment …

[引用][C] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆.

P Fenaux, D Haase, V Santini, GF Sanz… - Annals of Oncology …, 2020 - europepmc.org